Farallon Capital Management »

Urogen Pharma shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $220k 11k 19.95

More positions owned by Farallon Capital Management

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Aon Shs Cl A (AON)
Exelixis (EXEL)
Amazon (AMZN)
Natera (NTRA)
Revolution Medicines (RVMD)
UnitedHealth (UNH)
Thermo Fisher Scientific (TMO)
Hims & Hers Health Com Cl A (HIMS)
Walt Disney Company (DIS)
salesforce (CRM)
Autodesk (ADSK)

View all positions for Farallon Capital Management

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Morgan Stanley
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
Menora Mivtachim Holdings
Caption Management
Tang Capital Management
D. E. Shaw & Co
State Street Corporation

View all funds holding Urogen Pharma